Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biliary Tract Diseases | 2 | 2022 | 50 | 0.900 |
Why?
|
| Prostatic Neoplasms | 4 | 2021 | 778 | 0.890 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2021 | 2324 | 0.870 |
Why?
|
| Bile | 1 | 2022 | 35 | 0.810 |
Why?
|
| Cyclobutanes | 1 | 2021 | 2 | 0.810 |
Why?
|
| Cystadenoma, Serous | 1 | 2021 | 2 | 0.810 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2021 | 3 | 0.800 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 1 | 2021 | 1 | 0.770 |
Why?
|
| Silicon Dioxide | 6 | 2008 | 61 | 0.750 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2021 | 40 | 0.750 |
Why?
|
| Indium Radioisotopes | 3 | 2013 | 19 | 0.600 |
Why?
|
| Nanostructures | 2 | 2008 | 112 | 0.540 |
Why?
|
| Antibodies, Monoclonal | 3 | 2013 | 511 | 0.490 |
Why?
|
| Positron-Emission Tomography | 3 | 2021 | 160 | 0.460 |
Why?
|
| Gadolinium | 5 | 2013 | 88 | 0.450 |
Why?
|
| Radionuclide Imaging | 3 | 2022 | 166 | 0.440 |
Why?
|
| Contrast Media | 4 | 2013 | 595 | 0.420 |
Why?
|
| Multimodal Imaging | 1 | 2011 | 62 | 0.380 |
Why?
|
| Nanoparticles | 3 | 2013 | 254 | 0.370 |
Why?
|
| Organometallic Compounds | 5 | 2021 | 95 | 0.360 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2019 | 373 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 2223 | 0.310 |
Why?
|
| Lanthanoid Series Elements | 1 | 2007 | 3 | 0.300 |
Why?
|
| Cisplatin | 1 | 2008 | 192 | 0.300 |
Why?
|
| Nanocomposites | 1 | 2007 | 13 | 0.290 |
Why?
|
| Drug Delivery Systems | 2 | 2009 | 236 | 0.290 |
Why?
|
| Radiopharmaceuticals | 3 | 2021 | 114 | 0.280 |
Why?
|
| Organic Chemicals | 1 | 2006 | 77 | 0.260 |
Why?
|
| Radiation Dosage | 3 | 2019 | 419 | 0.250 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 38 | 0.250 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 10 | 0.200 |
Why?
|
| Carboxylic Acids | 1 | 2021 | 24 | 0.200 |
Why?
|
| Articulation Disorders | 1 | 2021 | 2 | 0.200 |
Why?
|
| Chylous Ascites | 1 | 2021 | 11 | 0.200 |
Why?
|
| Bile Ducts | 1 | 2022 | 59 | 0.200 |
Why?
|
| Cholecystectomy | 1 | 2022 | 79 | 0.200 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2013 | 137 | 0.190 |
Why?
|
| Colloids | 1 | 2021 | 43 | 0.190 |
Why?
|
| Humans | 18 | 2022 | 68618 | 0.190 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1070 | 0.190 |
Why?
|
| Tissue Distribution | 1 | 2021 | 282 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2021 | 84 | 0.180 |
Why?
|
| Algorithms | 3 | 2019 | 1196 | 0.180 |
Why?
|
| Spleen | 1 | 2021 | 301 | 0.180 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 150 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 174 | 0.170 |
Why?
|
| Neck | 1 | 2019 | 62 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 300 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 334 | 0.150 |
Why?
|
| Metal Nanoparticles | 2 | 2009 | 88 | 0.150 |
Why?
|
| X-Ray Diffraction | 2 | 2008 | 53 | 0.150 |
Why?
|
| Delayed-Action Preparations | 2 | 2008 | 120 | 0.150 |
Why?
|
| Radiography, Abdominal | 2 | 2014 | 57 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 565 | 0.140 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 239 | 0.140 |
Why?
|
| Liver | 1 | 2021 | 1118 | 0.130 |
Why?
|
| Prostate | 2 | 2013 | 116 | 0.120 |
Why?
|
| HT29 Cells | 3 | 2008 | 42 | 0.120 |
Why?
|
| Organosilicon Compounds | 1 | 2013 | 5 | 0.110 |
Why?
|
| Pelvic Neoplasms | 1 | 2013 | 13 | 0.110 |
Why?
|
| Professional Competence | 1 | 2013 | 100 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1173 | 0.110 |
Why?
|
| Male | 7 | 2021 | 37321 | 0.100 |
Why?
|
| Seminal Vesicles | 1 | 2011 | 7 | 0.100 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 247 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2013 | 1753 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 689 | 0.090 |
Why?
|
| Cryosurgery | 1 | 2010 | 53 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 306 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2013 | 442 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2010 | 82 | 0.090 |
Why?
|
| Particle Size | 2 | 2007 | 201 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2009 | 38 | 0.080 |
Why?
|
| Nanocapsules | 1 | 2009 | 10 | 0.080 |
Why?
|
| Manganese | 1 | 2008 | 26 | 0.080 |
Why?
|
| Terbium | 1 | 2008 | 5 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 4848 | 0.080 |
Why?
|
| Nanospheres | 1 | 2008 | 8 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2009 | 109 | 0.080 |
Why?
|
| Aged | 5 | 2022 | 14862 | 0.080 |
Why?
|
| Dicarboxylic Acids | 1 | 2007 | 16 | 0.070 |
Why?
|
| Povidone | 1 | 2007 | 12 | 0.070 |
Why?
|
| Middle Aged | 5 | 2022 | 21147 | 0.070 |
Why?
|
| Polymers | 1 | 2009 | 244 | 0.070 |
Why?
|
| Lymph Nodes | 2 | 2021 | 258 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2008 | 546 | 0.070 |
Why?
|
| Surface Properties | 1 | 2007 | 363 | 0.070 |
Why?
|
| Molecular Structure | 1 | 2007 | 397 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2021 | 7277 | 0.060 |
Why?
|
| Radiation Protection | 2 | 2014 | 71 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 561 | 0.050 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2022 | 9 | 0.050 |
Why?
|
| Yttrium Radioisotopes | 1 | 2022 | 4 | 0.050 |
Why?
|
| Forearm | 1 | 2022 | 25 | 0.050 |
Why?
|
| Microspheres | 1 | 2022 | 59 | 0.050 |
Why?
|
| Octreotide | 1 | 2021 | 21 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 72 | 0.050 |
Why?
|
| Paracentesis | 1 | 2021 | 25 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 81 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 211 | 0.040 |
Why?
|
| Monocytes | 2 | 2009 | 210 | 0.040 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 337 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 1342 | 0.040 |
Why?
|
| Adult | 2 | 2013 | 21403 | 0.040 |
Why?
|
| Biomarkers | 1 | 2022 | 1593 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 1851 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 2358 | 0.030 |
Why?
|
| Neoplasms | 1 | 2007 | 1667 | 0.030 |
Why?
|
| Intestinal Diseases | 1 | 2013 | 25 | 0.030 |
Why?
|
| Pelvis | 1 | 2013 | 38 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 2455 | 0.030 |
Why?
|
| Biodegradation, Environmental | 1 | 2013 | 92 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2013 | 46 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 330 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 2891 | 0.030 |
Why?
|
| Mice | 3 | 2009 | 8474 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 274 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2013 | 208 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2019 | 3187 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2013 | 189 | 0.030 |
Why?
|
| Brain | 1 | 2022 | 2176 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 191 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2010 | 138 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 349 | 0.020 |
Why?
|
| Synovitis | 1 | 2009 | 8 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2009 | 120 | 0.020 |
Why?
|
| Hindlimb | 1 | 2009 | 38 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 536 | 0.020 |
Why?
|
| Edema | 1 | 2009 | 66 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 215 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 282 | 0.020 |
Why?
|
| Tricarboxylic Acids | 1 | 2008 | 3 | 0.020 |
Why?
|
| Catalysis | 1 | 2009 | 123 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 52 | 0.020 |
Why?
|
| Rhodamines | 1 | 2008 | 27 | 0.020 |
Why?
|
| Microwaves | 1 | 2008 | 31 | 0.020 |
Why?
|
| Biosensing Techniques | 1 | 2009 | 51 | 0.020 |
Why?
|
| Pentetic Acid | 1 | 2008 | 18 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 800 | 0.020 |
Why?
|
| Child | 1 | 2019 | 6405 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2077 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 2008 | 57 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2008 | 152 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 236 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 317 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 127 | 0.020 |
Why?
|
| Luminescence | 1 | 2007 | 31 | 0.020 |
Why?
|
| Animals | 3 | 2009 | 20881 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 8912 | 0.020 |
Why?
|
| Macrophages | 1 | 2009 | 647 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 3705 | 0.020 |
Why?
|
| Female | 2 | 2019 | 38074 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 1752 | 0.010 |
Why?
|